THE SCHEDULE 13G

Company

Spero Therapeutics, Inc.

Filed

November 9, 2017

Accession Number

0000921895-17-002581

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →